313 related articles for article (PubMed ID: 5968054)
1. Clinical pharmacological studies with haloperidol.
Dunlop E
J New Drugs; 1966; 6(4):243-6. PubMed ID: 5968054
[No Abstract] [Full Text] [Related]
2. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Greger J; Glitschka A; Müller K
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
[No Abstract] [Full Text] [Related]
3. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
Rodová A; Náhunek K; Svestka J
Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
[No Abstract] [Full Text] [Related]
4. [Clinical therapeutic experiences with fluphenazine].
Pfeiffer WM
Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
[No Abstract] [Full Text] [Related]
5. Long term haloperidol therapy in outpatients.
Dunlop E
Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:87-94. PubMed ID: 4862423
[No Abstract] [Full Text] [Related]
6. Long-term effects of haloperidol.
Man PL
Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
[No Abstract] [Full Text] [Related]
7. Clinical experience with Melleril-Retard.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1970; 12(3):245-6. PubMed ID: 5457439
[No Abstract] [Full Text] [Related]
8. Clinical experience with octoclothepin.
Rydzyński Z; Wierzbicki T
Act Nerv Super (Praha); 1970 Jan; 12(1):46-7. PubMed ID: 5418655
[No Abstract] [Full Text] [Related]
9. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
[No Abstract] [Full Text] [Related]
10. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia].
Weiser G
Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494
[No Abstract] [Full Text] [Related]
11. Clinical experience with fluspirilene in psychoses.
Svestka J; Náhunek K; Hádlík J; Rodová A
Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825
[No Abstract] [Full Text] [Related]
12. [Comparative study of the activity of 2 neuroleptics].
Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM
Encephale; 1970; 59(2):97-161. PubMed ID: 5458713
[No Abstract] [Full Text] [Related]
13. The clinical determination of unique effect of potentiation of phenothiazine medication by nylidrin hydrochloride.
Chu J; Doering MF; Fogel EJ
Int J Neuropsychiatry; 1966 Feb; 2(1):53-9. PubMed ID: 5907814
[No Abstract] [Full Text] [Related]
14. Note on the treatment of depression.
Denber HC
Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:141-5. PubMed ID: 5328013
[No Abstract] [Full Text] [Related]
15. Flupenthixol versus haloperidol in acute psychosis.
Parent M; Toussaint C
Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol--a preliminary clinical study.
Holstein AP; Chen CH
Am J Psychiatry; 1965 Oct; 122(4):462-3. PubMed ID: 5825400
[No Abstract] [Full Text] [Related]
17. To the incompatibility of haloperidol with lithium salts.
Marhold J; Zimanová J; Lachman M; Král J; Vojtĕchovský M
Act Nerv Super (Praha); 1974 Aug; 16(3):199-200. PubMed ID: 4420744
[No Abstract] [Full Text] [Related]
18. [Use of haloperidol in residual schizophrenia and in the paranoid states].
Jeri FR
Rev Neuropsiquiatr; 1970 Jun; 33(2):114-22. PubMed ID: 5509272
[No Abstract] [Full Text] [Related]
19. [Current clinical experience with clothiapine (Entumin)].
Vencovský E; Peterová E; Baudis P
Cesk Psychiatr; 1970 Apr; 66(2):93-7. PubMed ID: 5444522
[No Abstract] [Full Text] [Related]
20. [On the position of butyrophenone derivative Triperidol in psychiatric treatment].
Lange E; Scholz V
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
